Paweł K. Kunicki, PhD, is an Assistant Professor at the Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Poland (since 2016). He graduated as a Master of Pharmacy (M.Pharm. 1990) and as a Doctor in Pharmaceutical Sciences (Pharm.D., Ph.D. 2002). From 1990–2019 he was at the Institute of Cardiology in Warsaw and was recently the Head of the Clinical Pharmacology Unit and acting Head of Department of Clinical Biochemistry. He is a clinical pharmacist as well as a laboratory diagnostician and specialist in Public Health (2011) and in Laboratory Medical Toxicology (2021). The main area of his interest has been the optimization of pharmacotherapy leading to the increased effectiveness and safety of treatments. This optimization is achieved through the individualization of drug dosage in the patient, with Therapeutic Drug Monitoring playing a leading role. He is a consultant and expert in the field of drug analysis, pharmacokinetics and bioequivalence studies. He is an author of 53 original and review papers and of 202 oral or poster scientific presentations and lectures; h-index: 12. He is a member of the IATDMCT (Immunosuppressive Drugs Committee), as well as an Editorial Board member of Therapeutic Drug Monitoring.
